A phase I trial of IONIS-FB-LRX in healthy volunteers.
Latest Information Update: 17 Aug 2017
At a glance
- Drugs IONIS FB LRX (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions
- 17 Aug 2017 New trial record
Latest Information Update: 17 Aug 2017